iShares Genomics Immunology and Healthcare ETF
iShares Genomics Immunology and Healthcare ETF (IDNA) Implied Volatility Current
IDNA's 30 day implied volatility is 44.92%, with an IV Rank of 87.30%. This is a high IV Rank versus the past year, meaning iShares Genomics Immunology and Healthcare ETF options are relatively expensive and currently favor sellers. IDNA's 30 day historical volatility sits at 41.00%, which means implied volatility is running 3.92 points above historical volatility, as of Nov 5, 2026.
Read more
Tracking IDNA implied volatility helps you spot when iShares Genomics Immunology and Healthcare ETF options are historically cheap or expensive, and where the best trades are hiding. When IDNA IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor IDNA implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking IDNA IV rank helps you see whether IDNA's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
Implied Volatility
IV is highly elevated. Premiums are expensive, strongly favoring sellers.
As of Nov 5, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →